• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白在评估成人炎症性肠病黏膜愈合中的应用:一项荟萃分析

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis.

作者信息

Bromke Mariusz A, Neubauer Katarzyna, Kempiński Radosław, Krzystek-Korpacka Małgorzata

机构信息

Department of Biochemistry and Immunochemistry, Wroclaw Medical University, Chalubinskiego 10, 50-368 Wroclaw, Poland.

Department of Gastroenterology and Hepatology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.

出版信息

J Clin Med. 2021 May 19;10(10):2203. doi: 10.3390/jcm10102203.

DOI:10.3390/jcm10102203
PMID:34069684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8161009/
Abstract

Achieving mucosal healing in patients with inflammatory bowel disease is related to a higher incidence of sustained clinical remission and it translates to lower rates of hospitalisation and surgery. The assessment methods of disease activity and response to therapy are limited and mainly rely on colonoscopy. This meta-analysis reviews the effectiveness of using faecal calprotectin as a marker for mucosal healing in inflammatory bowel disease. Two meta-analyses were conducted in parallel. The analysis on the use of faecal calprotectin in monitoring mucosal healing in colonic Crohn's disease is based on 16 publications (17 studies). The data set for diagnostic values of faecal calprotectin in ulcerative colitis is composed of 35 original publications (total 49 studies). The DOR for the use of faecal calprotectin in Crohn's disease is estimated to be 11.20 and the area under the sROCis 0.829. In cases of ulcerative colitis, the DOR is 14.48, while the AUC sROC is 0.858. Heterogeneity of the studies was moderatetosubstantial. Collected data show overall good sensitivity and specificity of the faecal calprotectin test, as well as a good DOR. Thus, monitoring of mucosal healing with a non-invasive faecal calprotectin test may represent an attractive option for physicians and patients with inflammatory bowel disease.

摘要

在炎症性肠病患者中实现黏膜愈合与持续临床缓解的较高发生率相关,并且这意味着更低的住院率和手术率。疾病活动度和对治疗反应的评估方法有限,主要依赖结肠镜检查。这项荟萃分析回顾了使用粪便钙卫蛋白作为炎症性肠病黏膜愈合标志物的有效性。同时进行了两项荟萃分析。关于粪便钙卫蛋白在监测结肠克罗恩病黏膜愈合中的应用分析基于16篇出版物(17项研究)。溃疡性结肠炎中粪便钙卫蛋白诊断价值的数据集由35篇原始出版物(共49项研究)组成。在克罗恩病中使用粪便钙卫蛋白的诊断比值比估计为11.20,sROC曲线下面积为0.829。在溃疡性结肠炎病例中,诊断比值比为14.48,而AUC sROC为0.858。研究的异质性为中度至高度。收集的数据显示粪便钙卫蛋白检测总体具有良好的敏感性和特异性,以及良好的诊断比值比。因此,使用非侵入性的粪便钙卫蛋白检测来监测黏膜愈合对于炎症性肠病的医生和患者可能是一个有吸引力的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/908683efdd46/jcm-10-02203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/dafcadfe8014/jcm-10-02203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/f870aa795a7e/jcm-10-02203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/4e8efe144b9c/jcm-10-02203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/908683efdd46/jcm-10-02203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/dafcadfe8014/jcm-10-02203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/f870aa795a7e/jcm-10-02203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/4e8efe144b9c/jcm-10-02203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/8161009/908683efdd46/jcm-10-02203-g004.jpg

相似文献

1
Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis.粪便钙卫蛋白在评估成人炎症性肠病黏膜愈合中的应用:一项荟萃分析
J Clin Med. 2021 May 19;10(10):2203. doi: 10.3390/jcm10102203.
2
Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?粪便标志物是炎症性肠病黏膜愈合的良好指标吗?
World J Gastroenterol. 2015 Oct 28;21(40):11469-80. doi: 10.3748/wjg.v21.i40.11469.
3
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.抗肿瘤坏死因子α制剂诱导治疗炎症性肠病后粪便钙卫蛋白检测:一年时临床反应和黏膜愈合的预测
Dig Liver Dis. 2014 Nov;46(11):974-9. doi: 10.1016/j.dld.2014.07.013. Epub 2014 Aug 2.
4
Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.粪便几丁质酶3样蛋白1是一种可靠的标志物,在检测成年炎症性肠病患者的内镜活动方面与粪便钙卫蛋白一样准确。
Aliment Pharmacol Ther. 2016 May;43(10):1069-79. doi: 10.1111/apt.13585. Epub 2016 Mar 8.
5
Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis.联合粪便钙卫蛋白和乙状结肠镜检查可预测儿童溃疡性结肠炎的黏膜愈合情况。
Eur J Gastroenterol Hepatol. 2020 Jan;32(1):17-21. doi: 10.1097/MEG.0000000000001550.
6
Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review.粪便钙卫蛋白能否预测炎症性肠病复发:一篇综述
Frontline Gastroenterol. 2018 Jan;9(1):23-28. doi: 10.1136/flgastro-2016-100686. Epub 2016 Apr 5.
7
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.粪便钙卫蛋白作为评估炎症性肠病患儿黏膜炎症严重程度的可靠非侵入性标志物。
Dig Liver Dis. 2008 Jul;40(7):547-53. doi: 10.1016/j.dld.2008.01.017. Epub 2008 Mar 20.
8
Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.粪便钙卫蛋白——炎症性肠病管理中的有用工具。
Swiss Med Wkly. 2012 Apr 5;142:w13557. doi: 10.4414/smw.2012.13557. eCollection 2012.
9
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab.基线时的血清肿瘤坏死因子-α预测英夫利昔单抗治疗克罗恩病患者的黏膜愈合情况。
Aliment Pharmacol Ther. 2020 Jul;52(2):284-291. doi: 10.1111/apt.15870. Epub 2020 Jun 7.
10
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.关于粪便钙卫蛋白作为炎症性肠病生物学标志物作用的问答
Dig Liver Dis. 2009 Jan;41(1):56-66. doi: 10.1016/j.dld.2008.05.008. Epub 2008 Jul 3.

引用本文的文献

1
Exclusive enteral nutrition in Crohn's disease pediatric patients: from clinical remission to transmural healing.克罗恩病儿科患者的全肠内营养:从临床缓解到透壁愈合
Med Pharm Rep. 2025 Jul;98(3):371-380. doi: 10.15386/mpr-2900. Epub 2025 Jul 30.
2
Changes in amino acid concentrations and the gut microbiota composition are implicated in the mucosal healing of ulcerative colitis and can be used as noninvasive diagnostic biomarkers.氨基酸浓度的变化和肠道微生物群组成与溃疡性结肠炎的黏膜愈合有关,可作为非侵入性诊断生物标志物。
Clin Proteomics. 2024 Nov 21;21(1):62. doi: 10.1186/s12014-024-09513-5.
3
Review Article: Green Management of IBD-New Paradigms for an Eco-Friendly Approach.

本文引用的文献

1
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey.COVID-19 与炎症性肠病:单中心调查中的患者知识和认知。
Medicina (Kaunas). 2020 Aug 13;56(8):407. doi: 10.3390/medicina56080407.
2
Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.粪便钙卫蛋白浓度评估溃疡性结肠炎患者治疗效果的诊断准确性。
Clin Gastroenterol Hepatol. 2021 Nov;19(11):2333-2342. doi: 10.1016/j.cgh.2020.08.019. Epub 2020 Aug 13.
3
Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis.
综述文章:炎症性肠病的绿色管理——生态友好型方法的新范式
Aliment Pharmacol Ther. 2025 Jan;61(1):65-74. doi: 10.1111/apt.18399. Epub 2024 Nov 18.
4
Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease.粪便钙卫蛋白和内镜评分:炎症性肠病黏膜愈合评估的临床实践基石。
World J Gastroenterol. 2024 Jun 28;30(24):3022-3035. doi: 10.3748/wjg.v30.i24.3022.
5
Mucosal Genes Encoding Clock, Inflammation and Their Mutual Regulators Are Disrupted in Pediatric Patients with Active Ulcerative Colitis.黏膜基因编码的时钟、炎症及其相互调节剂在活动性溃疡性结肠炎患儿中被破坏。
Int J Mol Sci. 2024 Jan 25;25(3):1488. doi: 10.3390/ijms25031488.
6
The search for gastrointestinal inflammation in autism: a systematic review and meta-analysis of non-invasive gastrointestinal markers.自闭症患者胃肠道炎症的研究:非侵入性胃肠道标志物的系统评价和荟萃分析。
Mol Autism. 2024 Jan 17;15(1):4. doi: 10.1186/s13229-023-00575-0.
7
British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance.英国胃肠病学会应对炎症性肠病结直肠癌监测中与新冠疫情相关积压问题的临时框架。
Gut. 2023 Sep;72(9):1631-1634. doi: 10.1136/gutjnl-2022-328309. Epub 2022 Sep 5.
8
Performance of Machine Learning Algorithms for Predicting Disease Activity in Inflammatory Bowel Disease.机器学习算法在预测炎症性肠病疾病活动中的性能。
Inflammation. 2023 Aug;46(4):1561-1574. doi: 10.1007/s10753-023-01827-0. Epub 2023 May 12.
9
Crohn's Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study.克罗恩病患者对疾病监测的体验与偏好:一项国际定性研究。
Crohns Colitis 360. 2023 Feb 25;5(2):otad012. doi: 10.1093/crocol/otad012. eCollection 2023 Apr.
10
Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.B细胞活化因子(BAFF)在炎症性肠病中的作用。
Diagnostics (Basel). 2021 Dec 27;12(1):45. doi: 10.3390/diagnostics12010045.
基于粪便检测对台湾溃疡性结肠炎患者黏膜愈合的预测价值:一项回顾性队列分析。
PeerJ. 2020 Jul 14;8:e9537. doi: 10.7717/peerj.9537. eCollection 2020.
4
React, reset and restore: Adaptation of a large inflammatory bowel disease service during COVID-19 pandemic.React,reset and restore:在 COVID-19 大流行期间对大型炎症性肠病服务进行的调整。
Clin Med (Lond). 2020 Sep;20(5):e183-e188. doi: 10.7861/clinmed.2020-0369. Epub 2020 Jul 27.
5
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study.粪便钙卫蛋白可预测接受生物疗法治疗的溃疡性结肠炎患者的黏膜愈合:一项前瞻性研究。
Clin Transl Gastroenterol. 2020 May;11(5):e00174. doi: 10.14309/ctg.0000000000000174.
6
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.使用先进的光学增强技术和组织学缓解预测 IBD 患者内镜缓解的粪便钙卫蛋白阈值。
Inflamm Bowel Dis. 2021 Apr 15;27(5):647-654. doi: 10.1093/ibd/izaa163.
7
Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults.成人炎症性肠病黏膜愈合的生化生物标志物
Diagnostics (Basel). 2020 Jun 2;10(6):367. doi: 10.3390/diagnostics10060367.
8
Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy.2019冠状病毒病大流行期间炎症性肠病患者的护理挑战:来自意大利北部“红色区域”的报告
Inflamm Bowel Dis. 2020 May 12;26(6):793-796. doi: 10.1093/ibd/izaa084.
9
Infliximab levels and antibodies in IBD-related peripheral arthralgia.英夫利昔单抗水平和抗体在炎症性肠病相关外周关节炎中的作用。
Int J Colorectal Dis. 2020 Jun;35(6):1141-1148. doi: 10.1007/s00384-020-03581-3. Epub 2020 Apr 15.
10
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study.生物标志物界值与克罗恩病内镜结局的关联:CALM 研究的事后分析。
Inflamm Bowel Dis. 2020 Sep 18;26(10):1562-1571. doi: 10.1093/ibd/izaa025.